Skip to content
CellsBin®
AboutScoutInsightPolaris
AboutScoutInsightPolaris

Resources · Publications

Scientific Evidence
& Publications

Peer-reviewed research advancing Rare-Cell Biology™ — detecting, isolating, and profiling the rarest cells across the Scout™, Insight™, and Polaris™ platforms.

Showing 1–5 of 5 publicationsPage 1 / 1

  • ASCO2026

    ASCO 2026: Assessment of long-term persistence and phenotypic features of BCMA CAR-T cells in patients with relapsed or refractory multiple myeloma treated with ciltacabtagene autoleucel.

    ↗
  • ASCO2026

    ASCO 2026: Blinded comparison of natural killer cell detection with AI-driven nanophotonic imaging versus traditional spectral flow cytometry: Development of the CB-Scout assay

    ↗
  • Human Microbiome2026

    S'Wipe: user-friendly stool collection for high-throughput gut metabolomics and multi-omics

    ↗
  • ASH2024

    ASH 2024: Enhanced Detection and Isolation of Rare Cells Using Multi-Modal Deep Learning

    ↗
  • Blood2024

    Blood: Transformer-Based Multi-Modal Deep-Learning for Enrichment-Free Highly Sensitive Detection and Isolation of Circulating Plasma Cells in Multiple Myeloma

    ↗

CellsBin footer

CellsBin®

CellsBin is a tech-bio company pioneering Rare-Cell Biology™ to expand precision medicine — revealing the rare cells that shape human health.

Branford, Connecticut, United States · Headquarters & CLIA laboratory

Products

Scout™Insight™Polaris™

Company

About

Resources

PublicationsNews

© 2026 CellsBin® — All Rights Reserved · Privacy Policy